CATNAP: Understanding Narcolepsy in Children and Adolescents

The CATNAP study is a registry for children and adolescents with narcolepsy. It aims to gather information to better understand how narcolepsy develops and progresses in young people. Researchers want to learn about how narcolepsy is identified and diagnosed, and what treatments are used and why they might change. This study is for children and adolescents under 18 who have a doctor-confirmed diagnosis of narcolepsy and can participate in English. There are no specific interventions being tested; instead, the study collects information over a period of up to four years. The study is currently unclear on its status but plans to enroll 500 participants and has 16 active sites, plus a virtual option for those anywhere in the United States.

Study design
This is an observational study, meaning researchers will collect information about participants over time without testing a specific treatment. It plans to enroll 500 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for up to 4 years to understand the natural history of narcolepsy and treatment outcomes.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04899947

Child and Adolescent Registry for Participants With Narcolepsy

Recruiting
Not specifiedUp to 17Observational
Jazz Pharmaceuticals
~500 participants
Updated 2024-08-15 on ClinicalTrials.gov

At a glance

Recruiting sites
16 of 25 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Improve Understanding of Natural History of Pediatric Narcolepsy
Measured over Up to 4 years
+2 more outcomes measured
Narcolepsy
25 sites across 15 states
Ohio4
Arizona2
Arkansas2
California2
District of Columbia2
Michigan2
Missouri2
Pennsylvania2
Director Clinical Trial Disclosure & Transparency
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Any child or adolescent with a physician-confirmed diagnosis of narcolepsy
Age less than 18 years
Willing to participate in the Registry and complete the informed consent form
Able to participate in English based registry

Exclusion

Age 18 years or more
Fail to complete the informed consent form
  • Improve Understanding of Natural History of Pediatric NarcolepsyUp to 4 years
  • Characterize the Presentation, Identification, and Diagnosis of Narcolepsy in Pediatric ParticipantsUp to 4 years
  • Understand Treatment Practices and Outcomes Captured by Treatment Regimen and Rational for ChangesUp to 4 years